ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)

Healthcare | Biotechnology

Swipe horizontally to view all columns.

Income Statement (Quarterly) 2026-04-06 2025-06-30
Revenue 233,699,000 233,699,000
Cost of Revenue 21,650,000 21,650,000
Gross Profit 212,049,000 212,049,000
Operating Expenses
R&D Expenses 0 0
SG&A Expenses 237,472,000 237,472,000
Operating Expenses 766,033,000 766,033,000
Operating Income -553,984,000 -553,984,000
Interest Expense 0 0
Income Before Tax -585,312,000 -585,312,000
Income Tax Expense 5,512,000 5,512,000
Net Income -590,768,000 -590,768,000
Per Share
EPS -1.73 -1.73
EPS Diluted 0.00 0.00